William Durham
Internal Medicine · Corbin, KYNPI 1093893216
Payments from drug & device makers
Across 120 payments — averaging $13.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$202
- Novartis$178
- Novo Nordisk$175
- Astellas Pharma US Inc$168
- Merck$136
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$116
- plus $587 from 14 others
What the payments were for
- Food & beverage$1,563100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 15 | $202 |
| Novartis | 12 | $178 |
| Novo Nordisk | 13 | $175 |
| Astellas Pharma US Inc | 8 | $168 |
| Merck | 22 | $136 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $116 |
| Amarin Pharma, Inc. | 9 | $111 |
| AstraZeneca | 6 | $74 |
| AbbVie | 3 | $57 |
| Boehringer Ingelheim | 4 | $53 |
| E.r. Squibb & Sons, L.L.C. | 4 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
| Johnson & Johnson | 3 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Lilly USA, LLC | 3 | $37 |
| Insmed, Inc. | 1 | $20 |
| Amgen | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Livanova USA, Inc. | 1 | $13 |
How this compares
$1,563 in reported general payments places this provider in the 70th percentile of 1,284 internal medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,090 | $308,248 |
| JardianceEmpagliflozin | 268 | $80,445 |
| NuplazidPimavanserin Tartrate | 21 | $51,769 |
| Dupixent SyringeDupilumab | 12 | $46,230 |
| XifaxanRifaximin | 16 | $46,047 |
| XareltoRivaroxaban | 131 | $37,182 |
| FarxigaDapagliflozin Propanediol | 102 | $29,593 |
| LinzessLinaclotide | 51 | $28,268 |
| RestasisCyclosporine | 59 | $27,027 |
| NuedextaDextromethorphan Hbr/Quinidine | 36 | $26,421 |
| EntrestoSacubitril/Valsartan | 71 | $21,696 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $18,150 |
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 166 | $17,195 |
| MyrbetriqMirabegron | 75 | $16,473 |
| Atorvastatin Calcium | 909 | $16,332 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $202 | $308,2481,090 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta | $53 | $101,852320 claims |
| AbbVieLinzess, Restasis | $57 | $55,295110 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $116 | $46,04716 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $74 | $44,506142 claims |
| Johnson & JohnsonXarelto | $41 | $37,182131 claims |
| NovartisEntresto | $178 | $21,69671 claims |
| Astellas Pharma US IncMyrbetriq | $168 | $16,47375 claims |
| Lilly USA, LLCTrulicity | $37 | $14,90817 claims |
| MerckJanuvia | $136 | $13,93550 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,284 internal medicine providers in Kentucky.
Other internal medicine in Corbin
- Mark AdamsLondon$15.4M
- Matthew WenkerErlanger$12.8M
- Jason ChesneyLouisville$6.3M
- Neil FarrisLexington$3M
- David JohnsonOwensboro$787K
- Hollis ClarkMurray$780K
- Fares KhaterWhitesburg$412K
- Christopher PhillipsPaducah$315K
- Cynthia Bowman-StroudPaducah$234K
- Bernard BuchananOwensboro$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.